We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNPR
251
PUT
DELISTED
Juniper Networks
JNPR
$4.09M 0.09%
166,600
-25,300
-13% -$629K
SGI
252
Somnigroup International
SGI
$13.7B
$4.08M 0.09%
+273,108
New +$3.66M
ACN icon
253
Accenture
ACN
$107B
$4.04M 0.09%
+50,000
New +$4.01M
RGP
254
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$4M 0.09%
+124,229
New +$3.5M
KTWO
255
DELISTED
K2M Group Holdings, Inc
KTWO
$3.97M 0.09%
+266,705
New +$4M
GG
256
DELISTED
Goldcorp Inc
GG
$3.91M 0.09%
+140,000
New +$3.48M
KMB icon
257
Kimberly-Clark
KMB
$36.4B
$3.88M 0.09%
36,421
-46,838
-56% -$4.98M
LRMR icon
258
Larimar Therapeutics
LRMR
$430M
$3.74M 0.08%
+15,774
New +$3.75M
PBH icon
259
Prestige Consumer Healthcare
PBH
$2.61B
$3.73M 0.08%
+110,000
New +$3.52M
TBCH
260
Turtle Beach Corp
TBCH
$278M
$3.7M 0.08%
+100,133
New +$4.14M
HASI icon
261
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.27B
$3.62M 0.08%
+252,699
New +$3.51M
RAS
262
DELISTED
RAIT Financial Trust
RAS
$3.6M 0.08%
+434,756
New +$3.51M
SBRA icon
263
Sabra Healthcare REIT
SBRA
$5.4B
$3.55M 0.08%
+123,664
New +$3.59M
TCF
264
DELISTED
TCF Financial Corporation Common Stock
TCF
$3.51M 0.08%
+125,000
New +$3.66M
LIN
265
DELISTED
LIN MEDIA LLC CLASS A COM
LIN
$3.51M 0.08%
+128,805
New +$3.24M
TCPI
266
DELISTED
TCP International Hldgs Ltd.
TCPI
$3.49M 0.08%
+340,476
New +$3.5M
WINT
267
DELISTED
Windtree Therapeutics Inc
WINT
$3.48M 0.08%
139,774
+10,504
+8% +$269K
EPC icon
268
Edgewell Personal Care
EPC
$1.31B
$3.47M 0.08%
+38,318
New +$3.15M
DAR icon
269
Darling Ingredients
DAR
$9.58B
$3.44M 0.08%
+164,661
New +$3.32M
META icon
270
CALL
Meta Platforms (Facebook)
META
$1.51T
$3.37M 0.07%
50,000
-200,200
-80% -$12.3M
OPB
271
DELISTED
Opus Bank Common Stock
OPB
$3.35M 0.07%
+115,421
New +$3.46M
BKD icon
272
Brookdale Senior Living
BKD
$3.42B
$3.3M 0.07%
+98,928
New +$3.22M
ZSPH
273
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$3.21M 0.07%
+111,672
New +$3.16M
HZNP
274
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.16M 0.07%
200,000
-257,760
-56% -$3.68M
DAL icon
275
PUT
Delta Air Lines
DAL
$60B
$3.1M 0.07%
+80,000
New +$3.02M

Similar funds

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.